Ticker Scorecard - ABCL Basics Company: AbCellera Biologics Inc. IPO Date: December 11, 2020 Sector: Healthcare Industry: Biotech Market Cap: $894.96M Activated in VL: True Average Daily Range Avg Daily Range: $0.41 | 3.00% Avg Daily Range (30 D): $0.11 | 3.42% Avg Daily Range (90 D): $0.09 | 3.06% Institutional Daily Volume Avg Daily Volume: 1.84M Avg Daily Volume (30 D): 3.98M Avg Daily Volume (90 D): 2.96M Trade Size Avg Trade Size (Sh.): 137 Avg Trade Size (Sh.) (30 D): 296 Avg Trade Size (Sh.) (90 D): 276 Institutional Trades Total Inst.Trades: 1,139 Avg Inst. Trade: $1.9M Avg Inst. Trade (30 D): $.68M Avg Inst. Trade (90 D): $.63M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.12M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.17M Avg Closing Volume: 202.75K     News Jun 13, 2024 @ 9:40 AM Down 57%, Is AbCellera Biologics a Buy on the Dip?... Source: newsfeedback@fool.com (Cory Renauer) May 8, 2024 @ 8:30 AM AbCellera Biologics (ABCL) Q1 2024 Earnings Call T... Source: newsfeedback@fool.com (Motley Fool Transcribing) May 7, 2024 @ 10:05 PM AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, M... Source: Zacks Equity Research May 1, 2024 @ 2:01 PM Cytokinetics (CYTK) May Report Negative Earnings: ... Source: Zacks Equity Research Apr 30, 2024 @ 2:01 PM Analysts Estimate AbCellera Biologics Inc. (ABCL) ... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.61 $-.17 $-.13 Diluted EPS $-.61 $-.17 $-.13 Revenue $ 32.96M $ 6.51M $ 7.32M Gross Profit $ $ $ Net Income / Loss $ -175.8M $ -51.11M $ -36.93M Operating Income / Loss $ -308.06M $ -93.66M $ -93.45M Cost of Revenue $ $ $ Net Cash Flow $ -45.78M $ -21.67M $ 24.74M PE Ratio